Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Aduro Biotech Inc.
DescriptionLive attenuated Listeria monocytogenes strain expressing the EGFRvIII and NY-ESO-1 antigens
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I
Standard IndicationBrain cancer
Indication DetailsTreat glioblastoma multiforme (GBM); Treat high-grade glioma
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today